This company listing is no longer active
Liminal BioSciences Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Liminal BioSciences.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Biotechs earnings growth | 31.8% |
Revenue growth rate | -149.8% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 10 Apr 2023 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2024 | N/A | N/A | N/A | N/A | 1 |
12/31/2023 | N/A | N/A | N/A | N/A | 1 |
12/31/2022 | 0 | -29 | -32 | -32 | N/A |
9/30/2022 | 0 | -31 | -38 | -38 | N/A |
6/30/2022 | 1 | -35 | -84 | -84 | N/A |
3/31/2022 | 0 | -42 | -86 | -86 | N/A |
12/31/2021 | 1 | -44 | -100 | -100 | N/A |
9/30/2021 | 1 | -48 | -114 | -114 | N/A |
6/30/2021 | 1 | -49 | -75 | -74 | N/A |
3/31/2021 | 1 | -35 | -75 | -74 | N/A |
12/31/2020 | 1 | -48 | -78 | -76 | N/A |
9/30/2020 | 1 | -75 | -87 | -85 | N/A |
6/30/2020 | 2 | -94 | -86 | -85 | N/A |
3/31/2020 | 3 | -232 | -109 | -105 | N/A |
12/31/2019 | 1 | -150 | -104 | -99 | N/A |
9/30/2019 | -8 | -299 | -95 | -89 | N/A |
6/30/2019 | 3 | -298 | -90 | -84 | N/A |
3/31/2019 | 23 | -194 | -73 | -68 | N/A |
12/31/2018 | 25 | -197 | -88 | -82 | N/A |
9/30/2018 | 43 | -131 | -91 | -85 | N/A |
6/30/2018 | 55 | -118 | -112 | -105 | N/A |
3/31/2018 | 39 | -115 | -128 | -120 | N/A |
12/31/2017 | 22 | -112 | -133 | -123 | N/A |
9/30/2017 | 37 | -109 | -139 | -129 | N/A |
6/30/2017 | 16 | -119 | -130 | -118 | N/A |
3/31/2017 | 16 | -112 | -127 | -114 | N/A |
12/31/2016 | 16 | -101 | -113 | -98 | N/A |
9/30/2016 | 26 | -74 | N/A | -76 | N/A |
6/30/2016 | 28 | -58 | N/A | -66 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if PJ2's forecast earnings growth is above the savings rate (0.2%).
Earnings vs Market: Insufficient data to determine if PJ2's earnings are forecast to grow faster than the German market
High Growth Earnings: Insufficient data to determine if PJ2's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: PJ2 is forecast to have no revenue next year.
High Growth Revenue: PJ2 is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if PJ2's Return on Equity is forecast to be high in 3 years time